Hepatorenal syndrome
Hepatorenal Syndrome[edit]

Hepatorenal Syndrome (HRS) is a medical condition characterized by the rapid deterioration of kidney function in individuals with severe liver disease, such as cirrhosis or fulminant liver failure. This syndrome represents a type of kidney failure where there are no apparent abnormalities in the kidney itself, but rather the kidney function is compromised due to the liver disease.
Classification[edit]
HRS is classified into two main types:
- Type 1 HRS: A rapidly progressing form leading to severe kidney failure within weeks.
- Type 2 HRS: A more gradual decline in kidney function, associated with refractory ascites.
Causes[edit]
The underlying cause of HRS is a significant decrease in blood flow to the kidneys due to alterations in the circulation caused by liver cirrhosis. Factors contributing to its development include:
- Portal hypertension
- Bacterial infections
- Use of diuretics
Symptoms[edit]
Symptoms of HRS often reflect those of the underlying liver disease and may include:
- Fatigue
- Jaundice
- Swelling of the abdomen (ascites)
- Confusion or difficulty thinking clearly
Diagnosis[edit]
Diagnosis of HRS is primarily clinical, based on the presence of advanced liver disease and reduced kidney function. Key diagnostic tests include:
- Blood tests to check kidney and liver function
- Imaging studies to exclude other causes of kidney failure
- Exclusion of other causes of acute kidney injury
Treatment[edit]
Treatment options for HRS focus on managing the symptoms and attempting to improve liver and kidney function. These may include:
- Vasoconstrictor drugs to improve kidney function
- Albumin infusions
- Management of underlying liver disease
- In severe cases, liver transplantation may be considered, which can also resolve the kidney failure in many cases.
Prognosis[edit]
The prognosis of HRS is generally poor without treatment, especially for Type 1 HRS, which can be rapidly fatal. Early diagnosis and treatment are crucial for improving outcomes.
See Also[edit]
External Links[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


